196 related articles for article (PubMed ID: 38715793)
1. Advances in artificial intelligence in thyroid-associated ophthalmopathy.
Yi C; Niu G; Zhang Y; Rao J; Liu G; Yang W; Fei X
Front Endocrinol (Lausanne); 2024; 15():1356055. PubMed ID: 38715793
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence CT screening model for thyroid-associated ophthalmopathy and tests under clinical conditions.
Song X; Liu Z; Li L; Gao Z; Fan X; Zhai G; Zhou H
Int J Comput Assist Radiol Surg; 2021 Feb; 16(2):323-330. PubMed ID: 33146848
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis and treatment of thyroid-associated ophthalmopathy.
Gould DJ; Roth FS; Soparkar CN
Aesthetic Plast Surg; 2012 Jun; 36(3):638-48. PubMed ID: 22083413
[TBL] [Abstract][Full Text] [Related]
4. Research progress and application of artificial intelligence in thyroid associated ophthalmopathy.
Diao J; Chen X; Shen Y; Li J; Chen Y; He L; Chen S; Mou P; Ma X; Wei R
Front Cell Dev Biol; 2023; 11():1124775. PubMed ID: 36760363
[TBL] [Abstract][Full Text] [Related]
5. An update on thyroid-associated ophthalmopathy in children and adolescents.
Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
7. The significance of ophthalmological features in diagnosis of thyroid-associated ophthalmopathy.
Huang X; Tang W; Shen Y; He L; Tong F; Liu S; Li J; Li P; Zhang Y; Ma X; Wei R; Yang W
Biomed Eng Online; 2023 Feb; 22(1):7. PubMed ID: 36739403
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
[TBL] [Abstract][Full Text] [Related]
9. [Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022)].
;
Zhonghua Yan Ke Za Zhi; 2022 Sep; 58(9):646-668. PubMed ID: 36069085
[TBL] [Abstract][Full Text] [Related]
10. An ensemble deep learning diagnostic system for determining Clinical Activity Scores in thyroid-associated ophthalmopathy: integrating multi-view multimodal images from anterior segment slit-lamp photographs and facial images.
Yan C; Zhang Z; Zhang G; Liu H; Zhang R; Liu G; Rao J; Yang W; Sun B
Front Endocrinol (Lausanne); 2024; 15():1365350. PubMed ID: 38628586
[TBL] [Abstract][Full Text] [Related]
11. Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Mishra S; Maurya VK; Kumar S; Ankita ; Kaur A; Saxena SK
Curr Eye Res; 2020 Nov; 45(11):1325-1341. PubMed ID: 32567373
[TBL] [Abstract][Full Text] [Related]
12. Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy.
Li Y; Ma J; Xiao J; Wang Y; He W
Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):203-210. PubMed ID: 37773288
[TBL] [Abstract][Full Text] [Related]
13. Research Progress of Artificial Intelligence Image Analysis in Systemic Disease-Related Ophthalmopathy.
Ji Y; Chen N; Liu S; Yan Z; Qian H; Zhu S; Zhang J; Wang M; Jiang Q; Yang W
Dis Markers; 2022; 2022():3406890. PubMed ID: 35783011
[TBL] [Abstract][Full Text] [Related]
14. [The stepwise establishment of standardized treatment for the thyroid eye disease].
Qian J
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):404-407. PubMed ID: 28606260
[TBL] [Abstract][Full Text] [Related]
15. [Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy].
Wu ZY; Song GX
Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):769-71. PubMed ID: 16191339
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-Associated Orbitopathy: Management and Treatment.
Hennein L; Robbins SL
J Binocul Vis Ocul Motil; 2022; 72(1):32-46. PubMed ID: 34874796
[TBL] [Abstract][Full Text] [Related]
18. [High serum cholesterol: a novel risk factor for thyroid associated ophthalmopathy?].
Ye XZ; Huang SS; Liu J; Lu B; Shao JQ
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):823-825. PubMed ID: 31665858
[TBL] [Abstract][Full Text] [Related]
19.
Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S;
Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769
[TBL] [Abstract][Full Text] [Related]
20. Global research on artificial intelligence in thyroid-associated ophthalmopathy: A bibliometric analysis.
Zhang X
Adv Ophthalmol Pract Res; 2024; 4(1):1-7. PubMed ID: 38196774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
